Investors Chronicle - magazine and web content

View more issues:

Articles in July, 2007 issue of Investors Chronicle - magazine and web content

• US shares: still cheap.
• Redrow rally on weak foundations.
• Sterling set to go higher.
• Derivatives meltdown?
• Hill is flat.
• Mid caps may ride again.
• Media types still looking attractive.
• B&B's flaccid chart.
• RPS carries on the good work.
• Rio's coalmine canary croaks.
• Diageo raises cheer for long term.
• AstraZeneca looks wobbly.
• Vodafone rings up long-distance gains.
• BP not done rising.
• Regus looking regal.
• Bad press hits Mears shares.
• The yield-return puzzle.
• MWB still seeking hotel deal.
• Profitable mix at James Latham.
• All change at Media Square.
• Dodging bullets.
• Productivity hopes rise.
• Investing in London's property market.
• Last orders?
• Rightmove conquers all.
• AssetCo primed for growth.
• Coppock: two buy signals.
• Can a company doctor sort out Chapelthorpe?
• Sainsbury attracts Qatari bid approach.
• British Airways to resume dividends.
• London office rents surge.
• Velti's odyssey.
• Patient Minoan.
• FTSE in retreat.
• Wolseley down but not out.
• Safety first.
• Accident Exchange awaits verdict.
• What Sally did next.
• Rathbone fund flows gather momentum.
• Resolution to merge with Friends Provident.
• Try it and see.
• RDF Media hit by Queen effect.
• Better times for Prestbury.
• New product launches boost Renishaw.
• FTSE falls away.
• Glaxo diagnosed with mixed symptoms.
• Small world fed by dumb money.
• Misys still on critical list.
• Proteome's hope value.
• Outlook uncertain for Cobra.
• TEG suffers from PFI delay.
• Begbies Traynor on growth trail.
• Rexam heads for Russia.
• Taking the REIT path.
• European can't see the nickel for the trees.
• FTSE builds on early gains.
• Worthington Nicholls feels chill.
• Abbot steady, not spectacular.
• Big jump for Pace Micro.
• Walker the talker.
• Gilt recommendations.
• Inflation threat to equities.
• Liquidity: what it is and why it matters.
• Biotech floats get sinking feeling.
• Low & Bonar benefits from stability.
• IC Bidwatch: New battle for Sainsbury.
• Glaxo's Cervarix boost.
• Pipex exits consumer broadband.
• Newmark is now in a growth phase.
• FTSE settles in positive territory.
• Solar Integrated Technologies (SIT).
• Bidders eye cheap and cheerful hotels.
• Dipford runs into flack.
• RAB digs for victory.
• BT disappoints.
• Aquarius Platinum loses its sparkle.
• CSR heads back down.
• Northern Rock cautious.
• Consolidator targets Quantica.
• DTZ defies doubters.

• 1
• 2
• 3
• 4
• 5